Plenary Presentations Highlight Tagrisso and Imfinzi’s Potential in Early Lung Cancer London, UK – This Tuesday, AstraZeneca confirmed that it is set to present new data across its oncology portfolio at the American Society of Clinical Oncology (ASCO) Annual Meeting from May 31 to June 4, 2024. More than 100 abstracts will feature 25 approved … Continue reading AstraZeneca Set to Showcase New Cancer Research at ASCO 2024